通貨 / GERN
GERN: Geron Corporation
1.40
USD
0.03
(2.10%)
GERNの今日の為替レートは、-2.10%変化しました。日中、通貨は1あたり1.39の安値と1.44の高値で取引されました。
Geron Corporationダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。 異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
GERN News
- SpyGlass Pharma appoints Elizabeth O’Farrell to board of directors
- Geron: I Think We've Seen This Movie Before (NASDAQ:GERN)
- Geron (GERN) Q2 Revenue Jumps 5,477%
- Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
- Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket
- Geron earnings beat, revenue topped estimates
- Geron appoints Harout Semerjian as new CEO amid RYTELO expansion
- Incyte (INCY) Surpasses Q2 Earnings and Revenue Estimates
- Goldman Sachs resumes Geron stock coverage with Sell rating on weak Rytelo sales
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges
- Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN)
- Geron showcases RYTELO benefits at oncology meetings
- Geron Corp stockholders approve equity plan amendments
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- GERN Lawsuit Alert! Class Action Lawsuit Against Geron Corporation - TipRanks.com
- ClearBridge Small Cap Growth Strategy Q1 2025 Commentary (Mutual Fund:LMOIX)
- Geron Corp.: A Compelling Potential Buying Opportunity Thanks To Bearish Comments (GERN)
- Biotech Stocks Q1 2025 Recap: Winners And Underperformers
- ROSEN, A LEADING LAW FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GERN
- ROSEN, A RANKED AND LEADING FIRM, Encourages Geron Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GERN
- Geron Corp: How Concerned Should We Be About Rytelo Sales? (NASDAQ:GERN)
- Why Geron Stock Is Plummeting Today
- Dow Dips Over 100 Points; TJX Earnings Top Views - AppLovin (NASDAQ:APP), Enveric Biosciences (NASDAQ:ENVB)
1日のレンジ
1.39
1.44
1年のレンジ
1.09
4.83
- 以前の終値
- 1.43
- 始値
- 1.44
- 買値
- 1.40
- 買値
- 1.70
- 安値
- 1.39
- 高値
- 1.44
- 出来高
- 3.342 K
- 1日の変化
- -2.10%
- 1ヶ月の変化
- 23.89%
- 6ヶ月の変化
- -23.91%
- 1年の変化
- -70.28%
30 8月, 土曜日